(Q37059543)

English

Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence

scientific article published on 02 July 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

neoplastic stem cells

1 reference

based on heuristic

inferred from title

6

object named as

Rie Horii

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Norikazu Masuda

8

object named as

Norikazu Masuda

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Yuichiro Miyoshi

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Tadahiko Shien

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Akiko Ogiya

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Naoko Ishida

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Kieko Yamazaki

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Yoshiya Horimoto

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Hiroyuki Yasojima

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Touko Inao

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Tomofumi Osako

11

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Masato Takahashi

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Nobumoto Tomioka

13

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Yumi Endo

14

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Mitsuchika Hosoda

15

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Hiroyoshi Doihara

16

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Shinichiro Miyoshi

17

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Hiroko Yamashita

18

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society

19

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

2 July 2016

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Breast Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

18

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

73

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Distinct EMT programs control normal mammary stem cells and tumour-initiating cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Markers for the identification of late breast cancer recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Breast cancer adjuvant therapy: time to consider its time-dependent effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Markers of tumor-initiating cells predict chemoresistance in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Cancer stem cells: mirage or reality?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Prospective identification of tumorigenic breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

29 September 2017

Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

27 June 2018

Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

27 June 2018

Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

4 September 2018

Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

4 September 2018

Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

4 September 2018

ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

4 September 2018

The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

4 September 2018

Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

4 September 2018

Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4930566

4 September 2018

The 2011 EBCTCG polychemotherapy overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/27368476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27368476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical utility of genetic signatures in selecting adjuvant treatment: Risk stratification for early vs. late recurrences

1 reference

https://pubmed.ncbi.nlm.nih.gov/27368476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27368476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S13058-016-0731-3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37059543&oldid=2199813953"